"Performance" Mega Genomics reported a net profit of RMB 27.021 million for the year, a decrease of 40%, and declared a final dividend of RMB 0.15 per share

阿斯達克財經網
2026.04.01 02:02

美因基因 (06667.HK) 公佈截至去年 12 月底止全年業績，營業額 2.47 億元人民幣 (下同)，按年升 50.5%。純利 2,702.1 萬元，按年跌 40%；每股盈利 0.14 元。派末期息 0.15 元，上年同期不派息。

非香港財務報告準則會計準則計，集團去年經調整淨利潤 4,197.4 萬元，升 6.9%。

Source: 阿斯達克財經網 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.